Sk. Katiyar et H. Mukhtar, TEA IN CHEMOPREVENTION OF CANCER - EPIDEMIOLOGIC AND EXPERIMENTAL STUDIES (REVIEW), International journal of oncology, 8(2), 1996, pp. 221-238
This review summarizes available information on epidemiological and ex
perimental data showing an association of tea consumption with cancer
prevention. Studies showing cancer risk associated with tea consumptio
n are also summarized. Tea is grown in about 30 countries and, next to
water, is the most widely consumed beverage in the world. Experimenta
l studies demonstrating the chemopreventive effects of tea have been c
onducted principally with green tea; limited studies have also assesse
d the usefulness of black tea. Majority of these studies have been car
ried out in skin tumor model system where consumption through drinking
water of water extracts of tea or a polyphenolic fraction isolated fr
om tea has been shown to afford protection against chemical carcinogen
- or ultraviolet radiation-induced skin tumorigenesis. Tea consumption
has also been shown to afford protection against chemical carcinogen-
induced lung, forestomach, esophagus, duodenum, pancreas, liver, breas
t and colon carcinogenesis in specific bioassay models. Evidence has a
lso accumulated showing that tea polyphenols prevent tumor promoter- a
nd ultraviolet B-induced inflammatory responses in murine skin. The sp
ecies and strains of animals, dose, route, frequency and duration of c
arcinogen administration, as well as types, route of administration an
d duration of tea or its polyphenolic component(s) treatment are descr
ibed in detail. A brief description regarding mechanism(s) responsible
for the broad chemopreventive effects of tea is provided. Epidemiolog
ic studies, though inconclusive, in general suggest a possible prevent
ive effect of tea consumption on human cancer. On the basis of availab
le information, epidemiologic and experimental studies are ongoing to
draw the possible relationship between tea consumption and cancer caus
ation and prevention. Appropriate strategies for future clinical chemo
prevention trials to translate animal data to human cancer risk are wa
rranted.